ArticleFrontiers in clinical diabetes and healthcare2022

Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis.

Elizabeth Sorvor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.